Boldzone 250 - Alphazone Pharmaceuticals

Ciba’s efforts to create a testosterone variant with reduced aromatization led to the development of boldenone undecylenate, which was launched as Parenabol in the 1960s. It offered extended anabolic activity through its long ester but failed to meet long-term expectations in clinical use. The product was withdrawn, only to find a second life in veterinary applications as Equipoise. Its ability to promote appetite, lean muscle growth, and erythropoiesis made it a fixture in equine care and later, in athletic enhancement circles.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Boldzone 250 by Alphazone Pharmaceuticals, consult with your doctor or healthcare professional.